The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Endoscope + Radiofrequency Ablation (RFA)-Global Market Insights and Sales Trends 2025
Synopsis
Radiofrequency ablation (RFA) is one of the most promising ablative techniques for BE. The technique uses a bipolar electrode that is available as a balloon-based device for primary circumferential ablation or as a cap-based device that can be mounted on the tip of the endoscope for focal ablation.
The global Endoscope + Radiofrequency Ablation (RFA) market size is expected to reach US$ 5339.2 million by 2029, growing at a CAGR of 5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Endoscope + Radiofrequency Ablation (RFA) in various end use industries. The expanding demands from the Cardiology Application, Pain Management, Oncology Application and Other Application, are propelling Endoscope + Radiofrequency Ablation (RFA) market. Focal Ablation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Others segment is estimated at % CAGR for the next seven-year period.
The key factors that boost the growth of the global endoscope + radiofrequency ablation (RFA) market include upsurge in demand for novel treatment methods for patients suffering from cancer, cardiovascular diseases, and disorders associated with chronic pain along with the benefits offered by this advanced treatment modality. Several research studies have concluded that radiofrequency ablation (RFA) treatment efficiently creates lesion in the targeted body parts while maintaining short procedure durations.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Endoscope + Radiofrequency Ablation (RFA), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Endoscope + Radiofrequency Ablation (RFA) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Endoscope + Radiofrequency Ablation (RFA) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Endoscope + Radiofrequency Ablation (RFA) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Endoscope + Radiofrequency Ablation (RFA) covered in this report include Boston Scientific Corporation Conmed Corporation, Medtronic Plc (Covidien Plc), Smith and Nephew Plc, Stryker Corporation, Halyard Health, Abbott Laboratories (St. Jude Medical, Inc.), AngioDynamics, Hologic and AtriCure, etc.
The global Endoscope + Radiofrequency Ablation (RFA) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific Corporation Conmed Corporation
Medtronic Plc (Covidien Plc)
Smith and Nephew Plc
Stryker Corporation
Halyard Health
Abbott Laboratories (St. Jude Medical, Inc.)
AngioDynamics
Hologic
AtriCure
Global Endoscope + Radiofrequency Ablation (RFA) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Endoscope + Radiofrequency Ablation (RFA) market, Segment by Type:
Focal Ablation
Others
Global Endoscope + Radiofrequency Ablation (RFA) market, by Application
Cardiology Application
Pain Management
Oncology Application
Other Application
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Endoscope + Radiofrequency Ablation (RFA) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Radiofrequency ablation (RFA) is one of the most promising ablative techniques for BE. The technique uses a bipolar electrode that is available as a balloon-based device for primary circumferential ablation or as a cap-based device that can be mounted on the tip of the endoscope for focal ablation.
The global Endoscope + Radiofrequency Ablation (RFA) market size is expected to reach US$ 5339.2 million by 2029, growing at a CAGR of 5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Endoscope + Radiofrequency Ablation (RFA) in various end use industries. The expanding demands from the Cardiology Application, Pain Management, Oncology Application and Other Application, are propelling Endoscope + Radiofrequency Ablation (RFA) market. Focal Ablation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Others segment is estimated at % CAGR for the next seven-year period.
The key factors that boost the growth of the global endoscope + radiofrequency ablation (RFA) market include upsurge in demand for novel treatment methods for patients suffering from cancer, cardiovascular diseases, and disorders associated with chronic pain along with the benefits offered by this advanced treatment modality. Several research studies have concluded that radiofrequency ablation (RFA) treatment efficiently creates lesion in the targeted body parts while maintaining short procedure durations.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Endoscope + Radiofrequency Ablation (RFA), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Endoscope + Radiofrequency Ablation (RFA) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Endoscope + Radiofrequency Ablation (RFA) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Endoscope + Radiofrequency Ablation (RFA) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Endoscope + Radiofrequency Ablation (RFA) covered in this report include Boston Scientific Corporation Conmed Corporation, Medtronic Plc (Covidien Plc), Smith and Nephew Plc, Stryker Corporation, Halyard Health, Abbott Laboratories (St. Jude Medical, Inc.), AngioDynamics, Hologic and AtriCure, etc.
The global Endoscope + Radiofrequency Ablation (RFA) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific Corporation Conmed Corporation
Medtronic Plc (Covidien Plc)
Smith and Nephew Plc
Stryker Corporation
Halyard Health
Abbott Laboratories (St. Jude Medical, Inc.)
AngioDynamics
Hologic
AtriCure
Global Endoscope + Radiofrequency Ablation (RFA) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Endoscope + Radiofrequency Ablation (RFA) market, Segment by Type:
Focal Ablation
Others
Global Endoscope + Radiofrequency Ablation (RFA) market, by Application
Cardiology Application
Pain Management
Oncology Application
Other Application
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Endoscope + Radiofrequency Ablation (RFA) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Endoscope + Radiofrequency Ablation (RFA)
1.1 Endoscope + Radiofrequency Ablation (RFA) Market Overview
1.1.1 Endoscope + Radiofrequency Ablation (RFA) Product Scope
1.1.2 Endoscope + Radiofrequency Ablation (RFA) Market Status and Outlook
1.2 Global Endoscope + Radiofrequency Ablation (RFA) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Endoscope + Radiofrequency Ablation (RFA) Market Size by Region (2018-2029)
1.4 Global Endoscope + Radiofrequency Ablation (RFA) Historic Market Size by Region (2018-2023)
1.5 Global Endoscope + Radiofrequency Ablation (RFA) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Endoscope + Radiofrequency Ablation (RFA) Market Size (2018-2029)
1.6.1 North America Endoscope + Radiofrequency Ablation (RFA) Market Size (2018-2029)
1.6.2 Europe Endoscope + Radiofrequency Ablation (RFA) Market Size (2018-2029)
1.6.3 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Market Size (2018-2029)
1.6.4 Latin America Endoscope + Radiofrequency Ablation (RFA) Market Size (2018-2029)
1.6.5 Middle East & Africa Endoscope + Radiofrequency Ablation (RFA) Market Size (2018-2029)
2 Endoscope + Radiofrequency Ablation (RFA) Market by Type
2.1 Introduction
2.1.1 Focal Ablation
2.1.2 Others
2.2 Global Endoscope + Radiofrequency Ablation (RFA) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Endoscope + Radiofrequency Ablation (RFA) Historic Market Size by Type (2018-2023)
2.2.2 Global Endoscope + Radiofrequency Ablation (RFA) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Endoscope + Radiofrequency Ablation (RFA) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Endoscope + Radiofrequency Ablation (RFA) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Endoscope + Radiofrequency Ablation (RFA) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Endoscope + Radiofrequency Ablation (RFA) Revenue Breakdown by Type (2018-2029)
3 Endoscope + Radiofrequency Ablation (RFA) Market Overview by Application
3.1 Introduction
3.1.1 Cardiology Application
3.1.2 Pain Management
3.1.3 Oncology Application
3.1.4 Other Application
3.2 Global Endoscope + Radiofrequency Ablation (RFA) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Endoscope + Radiofrequency Ablation (RFA) Historic Market Size by Application (2018-2023)
3.2.2 Global Endoscope + Radiofrequency Ablation (RFA) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Endoscope + Radiofrequency Ablation (RFA) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Endoscope + Radiofrequency Ablation (RFA) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Endoscope + Radiofrequency Ablation (RFA) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Endoscope + Radiofrequency Ablation (RFA) Revenue Breakdown by Application (2018-2029)
4 Endoscope + Radiofrequency Ablation (RFA) Competition Analysis by Players
4.1 Global Endoscope + Radiofrequency Ablation (RFA) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Endoscope + Radiofrequency Ablation (RFA) as of 2022)
4.3 Date of Key Players Enter into Endoscope + Radiofrequency Ablation (RFA) Market
4.4 Global Top Players Endoscope + Radiofrequency Ablation (RFA) Headquarters and Area Served
4.5 Key Players Endoscope + Radiofrequency Ablation (RFA) Product Solution and Service
4.6 Competitive Status
4.6.1 Endoscope + Radiofrequency Ablation (RFA) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Boston Scientific Corporation Conmed Corporation
5.1.1 Boston Scientific Corporation Conmed Corporation Profile
5.1.2 Boston Scientific Corporation Conmed Corporation Main Business
5.1.3 Boston Scientific Corporation Conmed Corporation Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions
5.1.4 Boston Scientific Corporation Conmed Corporation Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2018-2023)
5.1.5 Boston Scientific Corporation Conmed Corporation Recent Developments
5.2 Medtronic Plc (Covidien Plc)
5.2.1 Medtronic Plc (Covidien Plc) Profile
5.2.2 Medtronic Plc (Covidien Plc) Main Business
5.2.3 Medtronic Plc (Covidien Plc) Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions
5.2.4 Medtronic Plc (Covidien Plc) Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2018-2023)
5.2.5 Medtronic Plc (Covidien Plc) Recent Developments
5.3 Smith and Nephew Plc
5.3.1 Smith and Nephew Plc Profile
5.3.2 Smith and Nephew Plc Main Business
5.3.3 Smith and Nephew Plc Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions
5.3.4 Smith and Nephew Plc Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2018-2023)
5.3.5 Stryker Corporation Recent Developments
5.4 Stryker Corporation
5.4.1 Stryker Corporation Profile
5.4.2 Stryker Corporation Main Business
5.4.3 Stryker Corporation Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions
5.4.4 Stryker Corporation Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2018-2023)
5.4.5 Stryker Corporation Recent Developments
5.5 Halyard Health
5.5.1 Halyard Health Profile
5.5.2 Halyard Health Main Business
5.5.3 Halyard Health Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions
5.5.4 Halyard Health Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2018-2023)
5.5.5 Halyard Health Recent Developments
5.6 Abbott Laboratories (St. Jude Medical, Inc.)
5.6.1 Abbott Laboratories (St. Jude Medical, Inc.) Profile
5.6.2 Abbott Laboratories (St. Jude Medical, Inc.) Main Business
5.6.3 Abbott Laboratories (St. Jude Medical, Inc.) Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions
5.6.4 Abbott Laboratories (St. Jude Medical, Inc.) Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2018-2023)
5.6.5 Abbott Laboratories (St. Jude Medical, Inc.) Recent Developments
5.7 AngioDynamics
5.7.1 AngioDynamics Profile
5.7.2 AngioDynamics Main Business
5.7.3 AngioDynamics Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions
5.7.4 AngioDynamics Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2018-2023)
5.7.5 AngioDynamics Recent Developments
5.8 Hologic
5.8.1 Hologic Profile
5.8.2 Hologic Main Business
5.8.3 Hologic Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions
5.8.4 Hologic Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2018-2023)
5.8.5 Hologic Recent Developments
5.9 AtriCure
5.9.1 AtriCure Profile
5.9.2 AtriCure Main Business
5.9.3 AtriCure Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions
5.9.4 AtriCure Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2018-2023)
5.9.5 AtriCure Recent Developments
6 North America
6.1 North America Endoscope + Radiofrequency Ablation (RFA) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Endoscope + Radiofrequency Ablation (RFA) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Endoscope + Radiofrequency Ablation (RFA) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Endoscope + Radiofrequency Ablation (RFA) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Endoscope + Radiofrequency Ablation (RFA) Market Dynamics
11.1 Endoscope + Radiofrequency Ablation (RFA) Industry Trends
11.2 Endoscope + Radiofrequency Ablation (RFA) Market Drivers
11.3 Endoscope + Radiofrequency Ablation (RFA) Market Challenges
11.4 Endoscope + Radiofrequency Ablation (RFA) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
